A phase 1B, open label, dose escalation study to evaluat

Project: Research project

Project Details

Description

A phase 1B, open label, dose escalation study to evaluate safety, pharmacokinetics and pharmacodynamics of Axitnib in combination with crizotinib in patients with advanced solid tumors
StatusFinished
Effective start/end date6/22/156/30/20

Funding

  • PFIZER, INC.

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.